Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 9, 2014, Pages 780-788

  Banin, R M ^a   Hirata, B K S ^a   Andrade, I S ^a   Zemdegs, J C S ^a   Clemente, A P G ^b   Dornellas, A P S ^a   Boldarine, V T ^a   Estadella, D ^a   Albuquerque, K T ^c   Oyama, L M ^a   Ribeiro, E B ^a   Telles, M M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Akt phosphorylation; Body adiposity; Ginkgo biloba extract; Insulin tolerance; Obesity; Rats

Indexed keywords

CHOLESTEROL; GINKGO BILOBA EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE 1B; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; INSULIN RECEPTOR SUBSTRATE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GASTROCNEMIUS MUSCLE; HYPERGLYCEMIA; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MALE; NONHUMAN; OBESITY; PHYTOTHERAPY; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ADVERSE EFFECTS; ANALYSIS; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECTS; DYSLIPIDEMIAS; EATING; GINKGO BILOBA; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIA; INSULIN RESISTANCE; LIPID DIET; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WISTAR RAT;

ADIPOSITY; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, HIGH-FAT; DYSLIPIDEMIAS; EATING; GINKGO BILOBA; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIA; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTO-ONCOGENE PROTEINS C-AKT; RATS, WISTAR; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84906497306     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20142983     Document Type: Article

References (35)

1. Pereira-Lancha LO, Campos-Ferraz PL, Lancha AH Jr. Obesity: considerations about etiology, metabolism, and the use of experimental models. Diabetes Metab Syndr Obes 2012; 5: 75-87.
2. Pego-Fernandes PM, Bibas BJ, Deboni M. Obesity: the greatest epidemic of the 21st century? São Paulo Med J, 2011; 129: 283-284, doi: 10.1590/S1516-31802011000500001.
3. Yang ZH, Miyahara H, Takeo J, Katayama M. Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice. Diabetol Metab Syndr 2012; 4: 32, doi: 10.1186/1758-5996-4-32.
4. Trayhurn P. Adipose tissue in obesity-an inflammatory issue. Endocrinology 2005; 146: 1003-1005, doi: 10.1210/en.2004-1597.
5. Xu C, Yang X, Zu S, Han S, Zhang Z, Zhu G. Association between serum lipids, blood pressure, and simple anthropometric measures in an adult Chinese population. Arch Med Res 2008; 39: 610-617, doi: 10.1016/j.arcmed.2008.05.001.
6. Hilal Y, Acar TN, Koksal E, Gezmen KM, Akbulut G, Bilici S, et al. The association of anthropometric measurements and lipid profiles in Turkish hypertensive adults. Afr Health Sci 2011; 11: 407-413.
7. Park YM, Won JH, Yun KJ, Ryu JH, Han YN, Choi SK, et al. Preventive effect of Ginkgo biloba extract (GBB) on the lipopolysaccharide-induced expressions of inducible nitric oxide synthase and cyclooxygenase-2 via suppression of nuclear factor-kappaB in RAW 264.7 cells. Biol Pharm Bull 2006; 29: 985-990, doi: 10.1248/bpb.29.985.
8. DeFeudis FV, Papadopoulos V, Drieu K. Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol 2003; 17: 405-417, doi: 10.1046/j.1472-8206.2003.00156.x.
9. Mehlsen J, Drabaek H, Wiinberg N, Winther K. Effects of a Ginkgo biloba extract on forearm haemodynamics in healthy volunteers. Clin Physiol Funct Imaging 2002; 22: 375-378, doi: 10.1046/j.1475-097X.2002.00445.x.
10. Rostoker G, Behar A, Lagrue G. Vascular hyperpermeability in nephrotic edema. Nephron 2000; 85: 194-200, doi: 10.1159/000045661.
11. Kudolo G.B. The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic beta-cell function in response to glucose loading in normal glucose tolerant individuals. J Clin Pharmacol 2000; 40: 647-654, doi: 10.1002/j.1552-4604. 2000.tb05991.x.
12. Kudolo GB, Delaney D, Blodgett J. Short-term oral ingestion of Ginkgo biloba extract (EGb 761) reduces malondialdehyde levels in washed platelets of type 2 diabetic subjects. Diabetes Res Clin Pract 2005; 68: 29-38, doi: 10.1016/j.diabres.2004.08.007.
13. Tanaka S, Han LK, Zheng YN, Okuda H. [Effects of the flavonoid fraction from Ginkgo biloba extract on the postprandial blood glucose elevation in rats]. Yakugaku Zasshi 2004; 124: 605-611, doi: 10.1248/yakushi.124.605.
14. Kudolo GB, Wang W, Javors M, Blodgett J. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects-a double blind placebo-controlled, crossover study. Clin Nutr 2006; 25: 606-616, doi: 10.1016/j. clnu.2005.12.012.
15. Lladó I, Rodriguez-Cuenca S, Pujol E, Monjo M, Estrany ME, Roca P, et al. Gender effects on adrenergic receptor expression and lipolysis in white adipose tissue of rats. Obes Res 2002; 10: 296-305, doi: 10.1038/oby.2002.41.
16. Saponara R, Bosisio E. Inhibition of cAMP-phosphodiesterase by biflavones of Ginkgo biloba in rat adipose tissue. J Nat Prod 1998; 61: 1386-1387, doi: 10.1021/np970569m.
17. Dell'Agli M, Bosisio E. Biflavones of Ginkgo biloba stimulate lipolysis in 3T3-L1 adipocytes. Planta Med 2002; 68: 76-79, doi: 10.1055/s-2002-19876.
18. Drieu K, Vranckx R, Benassayad C, Haourigi M, Hassid J, Yoa RG, et al. Effect of the extract of Ginkgo biloba (EGb 761) on the circulating and cellular profiles of polyunsaturated fatty acids: correlation with the anti-oxidant properties of the extract. Prostaglandins Leukot Essent Fatty Acids 2000; 63: 293-300, doi: 10.1054/plef.2000.0217.
19. Goldberg Y, Boaz M, Matas Z, Goldberg I, Shargorodsky M. Weight loss induced by nutritional and exercise intervention decreases arterial stiffness in obese subjects. Clin Nutr 2009; 28: 21-25, doi: 10.1016/j.clnu.2008.10.001.
20. Fayh AP, Lopes AL, da Silva AM, Reischak-Oliveira A, Friedman R. Effects of 5% weight loss through diet or diet plus exercise on cardiovascular parameters of obese: a randomized clinical trial. Eur J Nutr 2013; 52: 1443-1450, doi: 10.1007/s00394-012-0450-1.
21. Tremblay F, Lavigne C, Jacques H, Marette A. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes. 2001; 50: 1901-1910, doi: 10.2337/diabetes.50.8.1901.
22. Kudolo G.B. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulindependent diabetes mellitus. J Clin Pharmacol 2001; 41: 600-611, doi: 10.1177/00912700122010483.
23. Vasseur M, Jean T, DeFeudis FV, Drieu K. Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes. Gen Pharmacol 1994; 25: 31-46, doi: 10.1016/0306-3623 (94)90007-8.
24. Buettner R, Scholmerich J, Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007; 15: 798-808, doi: 10.1038/oby. 2007.608.
25. Shah ZA, Sharma P, Vohora S.B. Ginkgo biloba normalises stress-elevated alterations in brain catecholamines, serotonin and plasma corticosterone levels. Eur Neuropsychopharmacol 2003; 13: 321-325, doi: 10.1016/S0924-977X (03)00005-1.
26. Figueiredo-Silva AC, Panserat S, Kaushik S, Geurden I, Polakof S. High levels of dietary fat impair glucose homeostasis in rainbow trout. J Exp Biol 2012; 215: 169-178, doi: 10.1242/jeb.063933.
27. Youngren JF, Paik J, Barnard R.J. Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulinresistant rats. J Appl Physiol 2001; 91: 2240-2247.
28. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999; 283: 1544-1548, doi: 10.1126/science.283.5407.1544.
29. Abdul-Ghani MA, DeFronzo R.A. Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol 2010; 2010: 476279, doi: http://dx.doi.org/10.1155/2010/476279.
30. Lu CJ, Sun Y, Muo CH, Chen RC, Chen PC, Hsu C.Y. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study. Cerebrovasc Dis 2013; 36: 145-151, doi: 10.1159/000353679.
31. Betteridge D.J. Thiazolidinediones and fracture risk in patients with Type 2 diabetes. Diabet Med 2011; 28: 759-771, doi: 10.1111/j.1464-5491.2010.03187.x.
32. Campbell I.W. Comparing the actions of older and newer therapies on body weight: to what extent should these effects guide the selection of antidiabetic therapy? Int J Clin Pract 2010; 64: 791-801, doi: 10.1111/j.1742-1241.2009. 02292.x.
33. El-Boghdady N.A. Increased cardiac endothelin-1 and nitric oxide in adriamycin-induced acute cardiotoxicity: protective effect of Ginkgo biloba extract. Indian J Biochem Biophys 2013; 50: 202-209.
34. Yeh GY, Davis RB, Phillips R.S. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 2006; 98: 673-680, doi: 10.1016/j.amjcard. 2006.03.051.
35. Lucinda LM, Vieira BJ, Oliveira TT, Sa RC, Peters VM, Reis JE, et al. Evidences of osteoporosis improvement in Wistar rats treated with Ginkgo biloba extract: a histomorphometric study of mandible and femur. Fitoterapia 2010; 81: 982-987, doi: 10.1016/j.fitote.2010.06.014.